Yutian WEI
14Patents
3h-index
18Co-inventors
49Inventor score
Filing activity: Feb 8, 2018 → Dec 27, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11066457B2 | Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereof | Chemistry; Metallurgy | 4 | Active |
| US11207349B2 | Combined chimeric antigen receptor targeting CD19 and CD20 and application thereof | Human Necessities | 4 | Active |
| US11608369B2 | Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereof | Chemistry; Metallurgy | 3 | Active |
| US11618778B2 | Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereof | Chemistry; Metallurgy | 3 | Active |
| US11439665B2 | Combined chimeric antigen receptor targeting CD19 and CD20 and application thereof | Human Necessities | 3 | Active |
| US11472858B2 | Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereof | Chemistry; Metallurgy | 3 | Active |
| US11633430B2 | Combined chimeric antigen receptor targeting CD19 and CD20 and application thereof | Human Necessities | 3 | Active |
| US12338494B2 | Reagent and method for fluorescence quantitative real-time PCR detection of RCL | Chemistry; Metallurgy | 0 | Active |
| US11331347B2 | Combined chimeric antigen receptor targeting CD19 and CD20 and application thereof | General | 0 | Revoked |
| US12311022B2 | Bispecific chimeric antigen receptors targeting CD20 and BCMA | Chemistry; Metallurgy | 0 | Active |
| US11142581B2 | BCMA-targeted chimeric antigen receptor as well as preparation method therefor and application thereof | Chemistry; Metallurgy | 0 | Active |
| US11697848B2 | Reagent and method for fluorescence quantitative real-time PCR detection of RCL | Chemistry; Metallurgy | 0 | Active |
| US11339200B2 | Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereof | General | 0 | Revoked |
| US11498973B2 | BCMA-targeted chimeric antigen receptor as well as preparation method therefor and application thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.